Our findings establish ET-1 as an early participant in aortic stiffening-induced hypertension and suggest that further exploration of ETA receptor blockade may provide a new strategy for the treatment of hypertension and associated vascular complications. This evidence concerns the gene EDN1 and hypertensive disorder.